Financial Performance - The company's statutory NPAT increased by 82% to $149.1 million compared to FY24[9] - Underlying EBITA increased by 25% to $474.2 million compared to FY24[9] - The company achieved an EBITA margin of 4.4%, exceeding the management target of 4.2%[9] - The company's cash conversion was 98%, exceeding the target of >90%[9] - The company's leverage ratio improved to 0.9x net debt to EBITDA, compared to 1.3x at Dec-24[9] - The company achieved annualised gross cost out of $213 million, exceeding the upsized target of $200 million[9] Revenue and Work-in-Hand - The company's FY25 revenue was $10.6 billion[101] - The company's work-in-hand is $35.1 billion[53] Shareholder Returns - The company announced an on-market share buy-back of up to $230 million, representing approximately 5% of issued capital[8, 73, 78] - The company's total dividend increased by 46% on FY24[9, 75] - The company's final dividend is 14.1cps, 100% franked[9] Outlook - The company is targeting underlying earnings and EBITA margin improvement in FY26, with underlying revenue forecast to be flat to slightly lower than FY25 pro forma revenue[84]

Financial Performance - Revenue reached $2482.6 million in FY25, comparable to $2475.1 million in FY24[43] - Underlying Profit Before Tax (PBT) was $22.3 million, compared to $56.8 million in FY24[5] - EBITDA was $110.1 million in FY25, down from $135.0 million in FY24[5] - Net tangible assets (NTA) stood at $1.42 per share[5] Operational Highlights - New car and demo inventory reduced to $343.1 million at FY25, excluding acquisitions since FY24[7,8] - Reduction in new car and demo inventory resulted in $32 million (-8%) decrease[7] - The company has 14+ Chinese brand dealerships[7] - Headcount reduced from 2300 to 1900, leading to lower costs[7] Sales Performance - New vehicle units sold were 31,242 in FY25, compared to 32,429 in FY24[20] - Used vehicle units sold increased to 9,702 in FY25, up from 8,520 in FY24[20] - Service & Parts Revenue increased to $422 million in FY25, compared to $405 million in FY24[20]

Financial Performance - Group revenue increased by 63% year-over-year to $390.4 million [26] - Precision Medicine revenue increased by approximately 30% year-over-year [26] - R&D investment increased by 47% year-over-year [26] - The company maintained positive operating cash flow of $17.7 million [26] - The company invested $241.8 million in strategic M&A [26] Business Segments - RLS revenue was $79.0 million, including third-party sales of PET and SPECT products [28, 29] - Precision Medicine gross margins remained stable at 64% [26, 36] - TMS (excluding RLS) experienced operating expenses that support expansion of global facilities and start-up and integration activities [38] Guidance and Future Outlook - The company reaffirmed FY 2025 revenue guidance of $770 million - $800 million [26, 48] - Research & Development (R&D) expenditure is expected to increase 20% - 25% compared to FY 2024 [49] Strategic Initiatives - The company completed target enrollment of 30 patients for ProstACT Global Phase 3 Part 1 [21, 109, 126] - The company received approval to commence IPAX-BrIGHT pivotal trial in glioblastoma (ex-U S) [21, 126] - The company is planning NDA resubmission for Pixclara® in approximately three months [21, 99]

Financial Highlights - Netwealth's total Funds Under Administration (FUA) reached $118.5 billion as of August 18, 2025[19, 125, 129] - FUA net flows increased by 40.4% from FY24 to $15.8 billion in FY25[19, 77] - Total income grew by 27.1% to $324.4 million in FY25[19, 77] - EBITDA increased by 31.1% to $163.5 million, with an EBITDA margin of 50.4%, a 3.2% increase[19] - Net Profit After Tax (NPAT) increased by 39.8% to $116.5 million[19, 77] Business Growth and Diversification - Managed Account FUM grew by 33.5% and Managed Funds FUM grew by 21.9%[30] - Domestic trade volume increased by 28.5%, while international trade volume increased significantly by 121.9%[30] - The number of financial intermediaries increased by 5.6% to 3,971, leading to a 13.3% increase in the number of accounts to 162,234[32] Revenue and Customer Segments - Transaction fee income increased by 47.7%, representing 14.0% of Platform Revenue[26, 84] - Management fee income increased by 31.1%, representing 6.1% of Platform Revenue[23, 84] - High Net Worth (HNW) FUA increased from 22.4% to 23.4%, and Ultra High Net Worth (UHNW) & Family Office FUA increased from 10.2% to 11.6%[52]

AMAERO LTD (ASX: 3DA | OTC: AMROF) A leading U.S. domestic producer of high -value refractory and titanium alloy spherical powders & manufacturer of near-net - shape parts for mission -critical components across defense, space, aviation, medical and industrials Investor Presentation August 2025 For personal use only Important Notice and Disclaimer This investor presentation (Presentation) is dated 21 August 2025 and has been prepared by Amaero Ltd (ACN 633 541 634) (Amaero) in relation to a non-underwritten ...

Financial Performance - SQM's Q2 2025 revenue reached US$1,043 million[7], gross profit was US$254 million[7], and net income totaled US$308 million[7] - Earnings per share stood at US$0.31[7] - Lithium LTM revenue reached $1,977 million[12], with a gross profit of $410 million[12] - Iodine LTM revenue reached US$985 million[23], with a gross profit of US$523 million[23] - Specialty Plant Nutrition LTM revenue reached US$946 million[33], with a gross profit of US$146 million[33] - Potassium LTM revenue reached US$217 million[40], with a gross profit of US$28 million[40] - Industrial Chemicals LTM revenue reached US$74 million[46], with a gross profit of US$28 million[46] Market Dynamics and Outlook - The global lithium market is expected to grow by approximately 17% in 2025[18] - SQM anticipates a sales volume growth of around 10% in the Lithium Chile division compared to 2024[18] - The company expects to sell approximately 20,000 tons of LCE for the International Lithium Division in 2025[18] - Global iodine demand growth is updated to less than 1% in 2025 compared to 2024[29] - SQM expects a market growth rate of around 4-5% in 2025 for Specialty Plant Nutrition[36] - Potassium sales volume for 2025 is expected to decline by 50% compared to 2024[42] Strategic Investments - Total Capex for 2025 is estimated at US$750 million, including maintenance[21] - Iodine and Nitrates total capex for 2025 is approximately US$350 million, including maintenance[31] Market Share - SQM holds approximately 17% of the global lithium chemical market[12] - SQM holds approximately 37% of the global iodine market[28] - SQM holds approximately 41% of the global KNO3 market[38] - SQM holds less than 1% of the global potash market[43] - SQM holds approximately 32% of the global industrial potassium nitrate market[49]

Financial Performance - GAAP Net Income was $102 million or $027 per share[11] - NAV-Based Total Return was 197% annualized[11] - Net Investment Income was $65 million or $017 per share[11] - Adjusted Net Investment Income was $66 million or $018 per share[11] - Net Asset Value was $2297 million or $612 per share as of June 30 2025[11] Investment Portfolio - The CLO portfolio grew by 27% to $3169 million as of June 30 2025 from $2499 million as of March 31 2025[11, 18] - CLO debt investments totaled $1489 million with 79% in the U S and 21% in Europe[11] - CLO equity investments totaled $1680 million with 92% in the U S and 8% in Europe[11] - The company purchased $906 million of CLO investments and sold $159 million[11] - The weighted average GAAP yield for the quarter based on amortized cost was 156% on the total CLO portfolio[11] Distributions - The company received $159 million in recurring cash distributions from the investment portfolio or $042 per share[11] - The distribution rate was 172% based on the August 18 2025 closing stock price of $559 and a monthly distribution of $008 per common share declared on August 7 2025[11]

Q2 2025 Financial Performance - Lowe's reported positive comparable sales growth of +1.1%[1] and a gross margin of 33.8%[1], which is an increase of +34 basis points compared to the previous year[1] - Adjusted operating margin reached 14.7%[2], up +23 basis points year-over-year[2], with diluted EPS at $4.27[2], a +2.4% increase[2], and adjusted diluted EPS at $4.33[2], a +5.6% increase[2] - The company returned $645 million to shareholders through dividends[2] Sales Trends - Comparable transactions decreased by -1.0%[3], while the comparable average ticket increased by +0.3% to $104.60[3] - Online sales growth experienced a decline of -6.4%[3] - Monthly comparable sales performance varied, with May at -1.8%[3], June at +2.9%[3], and July at +7.5%[3] - Comparable sales by ticket size showed growth in the >$500 range at +3.6%[3], a decrease in the $100-$500 range at -1.4%[3], and a decrease in the <$100 range at -0.1%[3] - Positive comparable sales were achieved in 9 out of 14 product categories[5], including Building Materials, Lawn & Garden, and Appliances[5] Strategic Initiatives - Lowe's closed on the acquisition of Artisan Design Group (ADG)[6] - Pro penetration has increased from approximately 19% in 2019 to approximately 30% in 2025[23] - Lowe's announced the acquisition of Foundation Building Materials (FBM) on August 20, 2025[12] Foundation Building Materials (FBM) Acquisition - FBM has approximately $6.5 billion in pro forma 2024 revenue and $635 million in adjusted EBITDA[27] - The purchase price of $8.8 billion reflects a multiple of 13.4x adjusted EBITDA[50]

Financial Performance - Second quarter revenues reached $84 million with a TCE (Time Charter Equivalent) rate of $72,000 per day[7] - Net income was $17.7 million, and adjusted net income was $24.8 million[7] - Earnings Per Share (EPS) was $0.33, and adjusted EPS was $0.46[7] Guidance and Outlook - The company reconfirmed its 2025 revenue guidance of approximately $340-360 million, with a TCE rate of $72,000-77,000 per day[7] - Adjusted EBITDA for 2025 is reconfirmed at around $250-270 million[7] Balance Sheet and Refinancing - Refinancing of Flex Courageous was completed, yielding net proceeds of approximately $43 million[27, 31] - Three refinancings are expected to generate around $132 million in net proceeds and lower the average pro forma cost of debt to approximately 5.6%[31] - The company's interest rate swap portfolio stood at $850 million (notional) with a weighted average rate of 2.33%[34] Dividends and Share Buy-Back - A dividend of $0.75 per share was declared for the second quarter[7] - The dividend per share for the last twelve months is $3.00[7] - A share buy-back program of up to $15 million has been launched[7, 39] Operational Updates - Two out of four planned drydockings have been completed ahead of schedule[8, 13] - The estimated average cost of all four drydockings is approximately $5.7 million per vessel[13] Market Trends - Global LNG exports YTD-2025 amounted to 244.7 MT, representing a 2% increase[41] - US LNG exports have surged, accompanied by approximately 24% growth in European LNG imports[40, 41]

Financial Performance - Total contract revenues increased by 14.5% from $1.2031 billion in Q2 2025 to $1.3779 billion in Q2 2026[5] - Organic revenue growth was 3.4%[5] - Adjusted EBITDA increased by 29.8% from $158.3 million in Q2 2025 to $205.5 million in Q2 2026[5] - Adjusted EBITDA margin improved by 175 bps from 13.2% in Q2 2025 to 14.9% in Q2 2026[5] - Adjusted diluted EPS increased by 35.4% from $2.46 in Q2 2025 to $3.33 in Q2 2026[5] Backlog and Outlook - Total backlog increased by 16.9% year-over-year[24] - Next 12 months backlog increased by 20.2% year-over-year[24] - The company reaffirms fiscal year 2026 revenue outlook range of $5.290 billion to $5.425 billion, representing a growth of 12.5% to 15.4% over the prior year[31] Debt and Liquidity - Total notional amount of debt was $1.035 billion in Q2 2026[25] - Notional net debt was $1.0065 billion in Q2 2026[25] - Liquidity was $545.9 million in Q2 2026[25]